cGMP Compliance for Supplement and Nutraceutical Brands: What AI Can (and Can't) Do Under 21 CFR Part 111

The supplement and nutraceutical industry has more FDA inspection exposure than most founders and operations leaders realize. 21 CFR Part 111 — the cGMP regulation governing dietary supplement manufacturing — contains over 100 specific requirements, and FDA's enforcement posture has sharpened considerably over the last three years. If you are manufacturing or co-manufacturing dietary supplements and you are not investing in your compliance infrastructure, you are running a risk that is entirely preventable.

AI automation can significantly reduce that risk. But only if it is deployed correctly — with a clear understanding of which Part 111 requirements AI can support, which require human oversight, and how to document AI-assisted processes in a way that survives an inspection.

The 5 Part 111 Requirements Most Frequently Cited in FDA 483s

Batch production records (§111.255–111.260). The most common 483 observation in supplement facilities involves incomplete or inconsistent batch production records. Part 111 requires that every step of the manufacturing process be documented with the date performed, the signature of the person performing the step, and documentation that the step was performed according to the master manufacturing record. Manual record-keeping creates gaps, transcription errors, and inconsistency across batches that are immediately visible to inspectors.

Identity testing of incoming components (§111.70–111.80). Part 111 requires that every lot of every dietary ingredient be positively identified before use. For facilities receiving 50–200 ingredient lots per month, the documentation burden of identity testing — receiving records, test results, release documentation — is substantial. Backlogs are common, and backlogs create 483 observations.

Supplier qualification and approved supplier lists (§111.70(b)). Facilities must establish specifications for each supplier and verify that incoming materials meet those specifications. Maintaining current, complete supplier files — including certificates of analysis, supplier audit records, and specification documentation — is an ongoing administrative burden that many smaller operations manage inconsistently.

Laboratory controls and in-process testing (§111.303–111.315). Part 111 requires that laboratory controls establish a system for testing and approving or rejecting components and finished batches. This includes documenting the test methods used, the results obtained, and the disposition decision for each lot. When test data and disposition decisions live in disconnected systems, the audit trail is fragmented and the inspection risk is high.

Consumer complaint files (§111.553–111.560). Every complaint that identifies a product or product lot must be reviewed to determine whether the complaint represents a potential failure of identity, purity, strength, or composition. Facilities that receive complaint files in multiple formats — email, phone logs, retailer chargebacks — and review them manually create inconsistent records that are difficult to defend in an inspection.

AI Candidates vs. Human Oversight Requirements

AI automation is well-suited for batch record documentation (automatically populating batch production records from connected equipment and process data), CoA verification (comparing incoming certificates of analysis against approved specifications and flagging deviations), supplier file maintenance (extracting and organizing supplier qualification data from incoming documentation), and complaint triage (classifying incoming complaints by product, lot, and complaint type and routing to the appropriate review queue).

Human oversight is required — and cannot be delegated to AI — for the identity testing decision itself (a qualified person must make the release or reject determination), the supplier qualification approval (a qualified person must approve new suppliers and specification changes), and the formal disposition decision for any batch or lot. AI can assemble the evidence package and flag the relevant information. The decision authority must remain with a qualified human reviewer.

Documenting AI-Assisted Processes for Inspection Readiness

The key to inspection readiness for AI-assisted Part 111 compliance is the same as for any other regulated process: documented procedures, validated systems, and a human-reviewed audit trail. Your SOPs must explicitly address how AI tools are used in each compliance workflow, what the human oversight checkpoint is, and how the AI output is recorded. Your validation documentation must establish that the AI system was tested and found suitable for its specific intended use in your facility. And your batch and lot records must include a reference to the AI-assisted review, the human reviewer, and the final disposition decision.

Inspectors are not opposed to AI. They are opposed to AI being used as a black box that makes compliance decisions without documentation. A well-documented AI-assisted process is more defensible in an inspection than a poorly documented manual one.